Healthcare News - An Overview
Novo CEO pressed by Senate to chop costs of being overweight, diabetes medicine CEO Lars Fruergaard Jørgensen instructed lawmakers the organization would consider new talks with insurers about the list prices of Wegovy and copyright whenever they pledge to keep the medicines on their formularies.Insurers will continue on vertically integrating to